Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-25-007236
Filing Date
2025-02-18
Accepted
2025-02-18 21:00:01
Documents
1
Period of Report
2025-02-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5958
  Complete submission text file 0001493152-25-007236.txt   8102
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Issuer) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 15 ATLANTIC AVENUE SUITE M2 LYNBROOK NY 11563
Business Address
Auerbach Shalom (Reporting) CIK: 0002048828 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42195 | Film No.: 25636971

Mailing Address 396 OAKLAND AVENUE CEDARHURST NY 11516
Business Address 396 OAKLAND AVENUE CEDARHURST NY 11516 917-364-7051
Einodmil LLC (Reporting) CIK: 0002048829 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-42195 | Film No.: 25636970